Since NFkB seems to be a critical player in NASH progression due to its central role in inflammation control by regulating the inflammatory cells infiltration as well as the expression of pro-inflammatory cytokines in both hepatocytes and Kupffer cells17, 18, targeting this pathway maybe of potential benefit in NASH. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.